Hanmi Pharm. Co., Ltd.

128940 KRX Pharmaceuticals Pharmaceuticals
KOSPI
₩464,000.00
-3.63%
Delayed · cached 15 min

Fair value analysis

128940
Hanmi Pharm. Co., Ltd.
Pharmaceuticals›Pharmaceuticals
₩464,000.00
Close used for this calculation
₩296,854.96Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
48/100
Profitability19/25
Returns7/25
Balance Sheet14/25
Efficiency8/25
Growth9/25
Average
Quality radar
48Prof.19/25Ret.7/25Eff.8/25B.Sht14/25Growth9/25

Consensus fair value

₩296,854.96
Above FV
▼ -36.0% against the close used
Model range ₩172,162.27 – ₩851,172.37
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₩172,162.27Fair value₩296,854.96Bull₩851,172.37
FairClose
52-week traded range
52W low ₩292,000.0052W high ₩626,000.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Hanmi Pharm. Co., Ltd. closed at ₩464,000.00, 56.3% above the consensus fair value of ₩296,854.96 drawn from 9 valuation models.

Financial DNA score 48/100 — Average. P/E of 34.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₩184,451.48
-60.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=9%, r=10%, tg=3%, n=10yr
Graham Number
₩172,162.27
-62.9%
√(22.5 × EPS × BVPS)
EPS=13372, BVPS=98513.8 · outside Graham range (P/E 34.7, P/B 4.7) — asset-light, treat as a rough floor
Graham Formula
₩851,172.37
+83.4%
EPS × (8.5 + 2g) × 4.4 ÷ FD_Rate
g=19.6%, FD=3.3%
P/E Fair Value
₩267,440.00
-42.4%
EPS × 20x (sector P/E)
EPS=13372, Sector P/E=20x
Peter Lynch (PEG)
₩262,358.64
-43.5%
EPS × Growth% (PEG = 1 is fair)
EPS=13372, g=19.6%
EV/EBITDA
₩412,097.20
-11.2%
(EBITDA × 18x − Net Debt) ÷ Shares
EBITDA=344B
Book Value (P/B)
₩186,437.37
-59.8%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=98513.8, ROE=13.6%, g=6%, r=10%
Reverse DCF
₩464,000.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 14.6% | Historical: 19.6%
Margin of Safety
₩276,604.90
-40.4%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=368806.53, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.